Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1051783 | 0.79 | EPHX1 (0.41) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL10133161 | 0.79 | CA1 (0.58) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL10115090 | 0.77 | EPHX1 (0.64) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL13194359 | 0.77 | EPHX1 (0.39) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL15609677 | 0.77 | EPHX1 (0.39) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL1051785 | 0.77 | EPHX1 (0.39) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL9111448 | 0.77 | EPHX1 (0.39) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL13972896 | 0.76 | EPHX1 (0.68) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL2111624 | 0.75 | — | — | |
| SCHEMBL23862451 | 0.74 | EPHX1 (0.46) | EPHX1GRIA1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210032229-A1 | PYRIDINE RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032229-A1 | PYRIDINE RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | CBR3, CBR1, H1-0 | EPHX1 444/4885CA1 3709/4885CA2 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.